24Sep/102:24 PM
Video: Warner Chilcott Buys U.S. Right to Enablex from Novartis
|
Warner Chilcott (WRCX) and Novartis (NVS) said today Warner Chilcott is buying the US rights to market Novartis Enablex, for a total of $420 million. Warner Chilcott is paying $400 million upfront for the US rights to the drug, which treats overactive bladder, as well as an additional $20 million in milestone payments. |
